Cargando…

HLX in AML: novel prognostic and therapeutic target

Detalles Bibliográficos
Autores principales:	Pandolfi, Ashley, Steidl, Ulrich
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2012
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717949/ https://www.ncbi.nlm.nih.gov/pubmed/23888188

Ejemplares similares

HLX affects cell cycle and proliferation in AML cells via the JAK/STAT signaling pathway
por: Zhu, Xia-Yin, et al.
Publicado: (2020)

A metabolic interplay coordinated by HLX regulates myeloid differentiation and AML through partly overlapping pathways
por: Piragyte, Indre, et al.
Publicado: (2018)

The ubiquitin-activating enzyme, UBA1, as a novel therapeutic target for AML
por: Barghout, Samir H., et al.
Publicado: (2018)

Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma
por: Nagel, Stefan, et al.
Publicado: (2018)

Targeting glutamine uptake in AML
por: Jacque, Nathalie, et al.
Publicado: (2014)

TBX21 and HLX1 Polymorphisms Influence Cytokine Secretion at Birth
por: Casaca, Vera Isabel, et al.
Publicado: (2012)

The Hlx homeobox transcription factor is required early in enteric nervous system development
por: Bates, Michael D, et al.
Publicado: (2006)

Epstein-Barr virus (EBV) activates NKL homeobox gene HLX in DLBCL
por: Nagel, Stefan, et al.
Publicado: (2019)

CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
por: Tettamanti, Sarah, et al.
Publicado: (2014)

Quality by Design–Based Assessment for Analytical Similarity of Adalimumab Biosimilar HLX03 to Humira®
por: Zhang, Erhui, et al.
Publicado: (2020)

Rs868058 in the Homeobox Gene HLX Contributes to Early-Onset Fetal Growth Restriction
por: Wujcicka, Wioletta Izabela, et al.
Publicado: (2022)

Acid ceramidase is upregulated in AML and represents a novel therapeutic target
por: Tan, Su-Fern, et al.
Publicado: (2016)

Targeting cistrome and dysregulated transcriptome of post-MPN sAML
por: Verstovsek, Srdan, et al.
Publicado: (2017)

MBRS-16. MYC REGULATED LONG NONCODING RNA LNC-HLX-2–7 IS A PUTATIVE MOLECULAR MARKER AND A THERAPEUTIC TARGET FOR GROUP 3 MEDULLOBLASTOMAS IN CHILDREN
por: Katsushima, Keisuke, et al.
Publicado: (2020)

Physicochemical and functional assessments demonstrating analytical similarity between rituximab biosimilar HLX01 and the MabThera®
por: Xu, Yanpeng, et al.
Publicado: (2019)

AML treatment in older adults
por: Sehgal, Alison, et al.
Publicado: (2015)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

How old is old: the beginning of a new era for therapeutic challenges for elderly patients with AML
por: Kim, Hee-Je
Publicado: (2014)

Hepatocyte growth factor regulates HLX1 gene expression to modulate HTR-8/SVneo trophoblast cells
por: Liu, Hai-Ying, et al.
Publicado: (2012)

A phase 3 study of rituximab biosimilar HLX01 in patients with diffuse large B-cell lymphoma
por: Shi, Yuankai, et al.
Publicado: (2020)

UCB HCT in FLT3+ AML
por: Ustun, Celalettin, et al.
Publicado: (2017)

Maintenance of elderly AML patients with androgens
por: Pigneux, Arnaud, et al.
Publicado: (2017)

In quest for leukemia initiating cells in AML
por: De Grandis, Maria, et al.
Publicado: (2018)

Novel Therapeutic Targets in Melanoma
por: Cerezo, Michaël, et al.
Publicado: (2023)

Novel Therapeutic Targets in Cancers
por: Levantini, Elena
Publicado: (2023)

Mutations in AML with a normal karyotype: NPM1 and FLT3-ITD, ready to use as a key prognosticator?
por: Kim, Hee-Je
Publicado: (2010)

Update of ALDH as a Potential Biomarker and Therapeutic Target for AML
por: Yang, Xiangchou, et al.
Publicado: (2018)

An In Vivo CRISPR Screening Platform for Prioritizing Therapeutic Targets in AML
por: Lin, Shan, et al.
Publicado: (2022)

Phospholipid metabolism regulates AML growth and stemness
por: Xu, Mingjing, et al.
Publicado: (2019)

Novel therapeutic target against Alzheimer
por: LeBlanc, Andrea C.
Publicado: (2017)

CALCRL Gene is a Suitable Prognostic Factor in AML/ETO(+) AML Patients
por: Wang, Rongrong, et al.
Publicado: (2022)

Identification of CD318 (CDCP1) as novel prognostic marker in AML
por: Heitmann, Jonas S., et al.
Publicado: (2020)

Phase I first-in-human study of HLX07, a novel and improved recombinant anti-EGFR humanized monoclonal antibody, in patients with advanced solid cancers
por: Hou, Ming-Mo, et al.
Publicado: (2021)

BRD4: A BET(ter) target for the treatment of AML?
por: Valent, Peter, et al.
Publicado: (2014)

Efficacy and safety of HLX01 in patients with moderate-to-severe rheumatoid arthritis despite methotrexate therapy: a phase 3 study
por: Zeng, Xiaofeng, et al.
Publicado: (2022)

Evaluating the efficacy and microenvironment changes of HER2 + gastric cancer during HLX02 and Endostar treatment using quantitative MRI
por: Liang, Jianye, et al.
Publicado: (2022)

Novel Therapeutic Targets for Tumor Microenvironment in Cancer
por: Bei, Roberto, et al.
Publicado: (2023)

Therapeutic effect of TRC105 and decitabine combination in AML xenografts
por: Baik, June, et al.
Publicado: (2020)

IRAK1: oncotarget in MDS and AML
por: Beverly, Levi J., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_204kfam1jdht04th4seok2551g